Related Experiment Videos
[Myocardial perfusion scintigraphy].
Hatem Hammami1, Habib Ben Brahim, Aida Mhiri
1Service de Médecine Nucléaire, Hôpital Militaire de Tunis.
La Tunisie Medicale
|October 11, 2003
Summary
Myocardial perfusion scintigraphy is a reliable diagnostic tool for coronary artery disease, offering high accuracy and prognostic value. This cost-effective imaging technique aids in risk stratification and patient management decisions.
Area of Science:
- Cardiology
- Nuclear Medicine
- Diagnostic Imaging
Background:
- Coronary artery disease (CAD) diagnosis relies on accurate imaging.
- Myocardial perfusion scintigraphy (MPS) is a key non-invasive diagnostic procedure.
Purpose of the Study:
- To review the diagnostic relevance of myocardial perfusion scintigraphy for coronary artery disease.
- To highlight its role in risk stratification and patient management.
Main Methods:
- Exercise or pharmacological stress (Dipyridamole) followed by scintigraphy.
- Common tracers include Thallium-201, sestamibi-Tc99m, and tetrofosmin-Tc99m.
- Gated single-photon emission computed tomography (SPECT) for combined perfusion and function assessment.
Main Results:
- MPS demonstrates high sensitivity (93%) and good specificity (80%) for CAD diagnosis.
- Established prognostic value in patients with known CAD.
- Thallium-201 SPECT accurately assesses myocardial viability and post-revascularization status.
Conclusions:
- Myocardial perfusion scintigraphy is a reliable and cost-effective investigation for CAD.
- It plays a crucial role in risk stratification and guiding patient management.
- Its established accuracy supports its continued use in clinical practice.